New Drug's first human test: is it safe?
NCT ID NCT07324642
Summary
This was an early safety study to see how healthy adults tolerate a new drug called KINE-101. Twenty-four healthy volunteers received daily intravenous doses for one week at three different dose levels, while some received a placebo. The main goal was to check for side effects and see how the drug moves through and is processed by the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, 28644, South Korea
Conditions
Explore the condition pages connected to this study.